A total of 3,888 pigs (337 × 1050, PIC, Hendersonville, TN; initially 6.0 ± 0.23 kg) were used in a 35-d study. At the time of placement, pens of pigs were weighed and allotted to 1 of 3 dietary treatments in a randomized complete block design with blocking structure including sow farm origin, date of entry into the facility, and average pen BW. A total of 144 pens were used with 72 double-sided 5-hole stainless steel fence line feeders, with one feeder serving as the experimental unit. For each feeder, 1 pen contained 27 gilts, and 1 pen contained 27 barrows. There were 24 replicates per dietary treatment. Diets were fed in three phases, and all contained 0.3 mg/kg added Se. A common phase 1 diet contained added Se from sodium selenite and was fed in pelleted form to all pigs from d -7 to approximately d 0. Three Se sources sodium selenite, Se yeast, and hydroxy-selenomethionine (OH-SeMet) were used to formulate 3 experimental diets in meal form for phase 2 (d 0 to 14) and phase 3 (d 14 to 35). During the pre-treatment period (d -7 to 0), there was a tendency (P = 0.097) of a difference in ADFI between treatments, although no significant pairwise differences were observed (P > 0.05). There were no other differences in growth performance between treatments from d -7 to 0. Clinical disease attributed to Streptococcus suis was observed within the trial between d 0 and 14, and water-soluble antimicrobial therapy was administered to all treatment groups for 7 d. From d 0 to 35, pigs fed OH-SeMet tended to have decreased ADG (P < 0.10) and had increased (P < 0.05) serum and tissue selenium concentration compared to other treatments. There was marginally significant evidence of a source × day interaction (P = 0.027) for total antioxidant capacity (T-AOC) where the numerical increase over time was less for the OH-SeMet than sodium selenite or selenium yeast treatments. There was no difference (P > 0.05) in antioxidant status as measured by serum GSH-Px or TBARS assay between treatments. In summary, compared to sodium selenite and selenium yeast, OH-SeMet may have a greater bioavailability as indicated by increased serum and tissue selenium concentration; however, antioxidant status was similar between treatments and OH-SeMet tended to reduce growth performance compared with pigs fed sodium selenite.